$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
0.05%58.790.6%$968.82m
PFEPfizer Inc.
0.17%34.830.7%$735.33m
JNJJohnson & Johnson
0.40%119.040.8%$722.76m
MRKMerck & Co., Inc.
0.87%62.861.1%$715.86m
ABBVAbbVie, Inc.
-0.16%64.622.9%$438.10m
LLYEli Lilly and Company
0.32%78.260.7%$249.27m
AZNAstraZeneca PLC Sponsored ADR
-0.54%33.051.2%$207.47m
NVONovo Nordisk A/S Sponsored ADR Class B
0.11%46.900.1%$160.08m
GSKGlaxoSmithKline plc Sponsored ADR
-0.45%43.550.3%$109.04m
NVSNovartis AG Sponsored ADR
-0.34%79.280.2%$91.32m
SNYSanofi Sponsored ADR
0.92%38.810.1%$68.87m
LCILannett Company, Inc.
-1.72%34.2320.3%$36.69m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.36%11.073.8%$3.78m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.95%9.590.2%$0.04m
EPIXESSA Pharma Inc
-2.26%2.600.0%$0.01m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.